Central Institute for Cardiovascular Research
The Central Institute for Cardiovascular Research (ZIHK), called the Central Institute for Cardiovascular Regulation Research from its founding until the end of June 1980 , was a non-university research institute of the Academy of Sciences of the GDR that existed from January 1, 1972 to December 31, 1991 ( AdW). In the German Democratic Republic (GDR) it acted as a lead facility for the treatment and research of cardiovascular diseases and from September 1984 it was the World Health Organization's Collaborating Center . The successor to the institute is the Max Delbrück Center for Molecular Medicine, founded in 1992 .
history
Organizational development
The Central Institute for Cardiovascular Research was created as part of a structural reform of the institutes of the German Academy of Sciences in Berlin from the Institute for Cortico-Visceral Pathology and Therapy and the Institute for Cardiovascular Research, which is part of a department of the Academy Institute for Medicine and Biology founded in 1947 decreased. It had its seat together with the Central Institute for Molecular Biology and the Central Institute for Cancer Research in Berlin-Buch . The institute was part of the Academy's Research Center for Molecular Biology and Medicine, which was established in 1971, and from 1986, together with the Central Institute for Cancer Research, was assigned to the medical science department of the AdW. From 1984 it acted as the World Health Organization (WHO) collaborating center for research and training in the field of cardiovascular diseases.
Tasks and activities
The Central Institute for Cardiovascular Research, which had around 450 employees in 1985, acted in the GDR as a control center for combating cardiovascular diseases . The institute's main research areas included basic research into the causes of arterial hypertension and coronary heart disease , the investigation of the regulation of the cardiovascular system and the role of the central nervous system , research into the molecular and cell biology of the heart and the vascular system, and education the causes of myocardial infarction and sudden cardiac death . In addition, the institute was responsible for the development and evaluation of new drug and equipment therapy approaches for the treatment of cardiovascular diseases.
Directors
The founding director of the Central Institute for Cardiovascular Research and medical director of the associated clinic with around 80 beds was Rudolf Baumann , who had headed the Institute for Cortico-Visceral Pathology and Therapy since 1958. He was followed from 1978 to 1990 by Horst Heine and from 1990 to 1991 by Karlheinz Richter . Albert Wollenberger , who previously headed the Institute for Circulatory Research, became department director at the ZIHK.
Successor organization
After German reunification , the Max Delbrück Center for Molecular Medicine (MDC), a special cardiological hospital named after the German internist Franz Volhard , and cancer treatment emerged as the successor institutions to the three central institutes based in Berlin-Buch the Robert Rössle Clinic. The two clinics, which cooperate with the MDC in the field of research, belonged to the Charité Universitätsmedizin Berlin until 2001 , after the Free University of Berlin was responsible for the sponsorship until 1998 . The clinics have been part of the Helios Clinic Berlin-Buch of the private Helios Group since 2001 .
literature
- Central Institute for Cardiovascular Research (ZIHK). In: Heinz Bielka : History of the medical-biological institutes Berlin-Buch. Second edition. Springer-Verlag, Berlin and Heidelberg 2002, ISBN 978-3-540-42842-8 , pp. 102/103